Follow The Leader: Looking Across The IO Landscape, An Infographic
Executive Summary
While interest in immuno-oncology runs deep across the industry, a handful of companies are leading the pack. Scrip offers a side-by-side look at the IO portfolios for BMS, Merck, Roche and AstraZeneca.
You may also be interested in...
2017 – Scrip Readers’ Pharma Year In Review
As we enter a new year, Scrip reviews some of the biggest overall themes which attracted our readers over the last 12 months.
2017 – Scrip Readers’ Pharma Year In Review
As we enter a new year, Scrip reviews some of the biggest overall themes which attracted our readers over the last 12 months.
Pipeline Watch: Six Approvals And 15 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.